125 related articles for article (PubMed ID: 15613104)
1. Bone marrow expression of vascular endothelial growth factor in myelofibrosis with myeloid metaplasia.
Ho CL; Arora B; Hoyer JD; Wellik LE; Mesa RA; Tefferi A
Eur J Haematol; 2005 Jan; 74(1):35-9. PubMed ID: 15613104
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasia.
Arora B; Ho CL; Hoyer JD; Mesa RA; Tefferi A
Haematologica; 2004 Dec; 89(12):1454-8. PubMed ID: 15590395
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression.
Panteli K; Zagorianakou N; Bai M; Katsaraki A; Agnantis NJ; Bourantas K
Eur J Haematol; 2004 Jun; 72(6):410-5. PubMed ID: 15128419
[TBL] [Abstract][Full Text] [Related]
4. Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia.
Lee CY; Tien HF; Hu CY; Chou WC; Lin LI
Br J Cancer; 2007 Oct; 97(7):877-82. PubMed ID: 17848952
[TBL] [Abstract][Full Text] [Related]
5. CD147 and VEGF co-expression predicts prognosis in patients with acute myeloid leukemia.
Fu J; Fu J; Chen X; Zhang Y; Gu H; Bai Y
Jpn J Clin Oncol; 2010 Nov; 40(11):1046-52. PubMed ID: 20558462
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow immunohistochemical studies of angiogenic cytokines and their receptors in myelofibrosis with myeloid metaplasia.
Chou JM; Li CY; Tefferi A
Leuk Res; 2003 Jun; 27(6):499-504. PubMed ID: 12648509
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of myelofibrosis with myeloid metaplasia.
Tefferi A
J Clin Oncol; 2005 Nov; 23(33):8520-30. PubMed ID: 16293880
[TBL] [Abstract][Full Text] [Related]
9. Analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor for overall survival.
Loges S; Heil G; Bruweleit M; Schoder V; Butzal M; Fischer U; Gehling UM; Schuch G; Hossfeld DK; Fiedler W
J Clin Oncol; 2005 Feb; 23(6):1109-17. PubMed ID: 15718307
[TBL] [Abstract][Full Text] [Related]
10. PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor of vascular endothelial growth factor (VEGF), has modest activity in myelofibrosis with myeloid metaplasia.
Giles FJ; List AF; Carroll M; Cortes JE; Valickas J; Chen BL; Masson E; Jacques C; Laurent D; Albitar M; Feldman EJ; Roboz GJ
Leuk Res; 2007 Jul; 31(7):891-7. PubMed ID: 17560285
[TBL] [Abstract][Full Text] [Related]
11. [The correlation of vascular endothelial growth factor with angiogenesis and p53 gene in laryngeal squamous cell carcinoma].
Yaylaci A; Cakir S; Güneş P; Akkaynak AC; Naiboğlu B; Gökçeer T
Kulak Burun Bogaz Ihtis Derg; 2006; 16(3):105-11. PubMed ID: 16763427
[TBL] [Abstract][Full Text] [Related]
12. Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia.
Keith T; Araki Y; Ohyagi M; Hasegawa M; Yamamoto K; Kurata M; Nakagawa Y; Suzuki K; Kitagawa M
Br J Haematol; 2007 May; 137(3):206-15. PubMed ID: 17408459
[TBL] [Abstract][Full Text] [Related]
13. Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia.
Hou HA; Chou WC; Lin LI; Tang JL; Tseng MH; Huang CF; Yao M; Chen CY; Tsay W; Tien HF
Leuk Res; 2008 Jun; 32(6):904-12. PubMed ID: 17904634
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow histochemical studies of fibrogenic cytokines and their receptors in myelodysplastic syndrome with myelofibrosis and related disorders.
Yoon SY; Li CY; Lloyd RV; Tefferi A
Int J Hematol; 2000 Oct; 72(3):337-42. PubMed ID: 11185990
[TBL] [Abstract][Full Text] [Related]
15. Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis.
Di Raimondo F; Azzaro MP; Palumbo GA; Bagnato S; Stagno F; Giustolisi GM; Cacciola E; Sortino G; Guglielmo P; Giustolisi R
Leukemia; 2001 Jun; 15(6):976-80. PubMed ID: 11417486
[TBL] [Abstract][Full Text] [Related]
16. [Bone marrow microvessel density and vascular endothelial growth factor expression in patients with aplastic anemia].
Zhang L; Wang HJ; Li HQ; Yang DL; Yan ZS; Wu YH; Zhou K; Chu YL; Chen HS; Zhang FK
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):528-31. PubMed ID: 18078128
[TBL] [Abstract][Full Text] [Related]
17. Expression of VEGF-C and its receptor VEGFR-3 in the bone marrow of patients with acute myeloid leukaemia.
Liersch R; Schliemann C; Bieker R; Hintelmann H; Buechner T; Berdel WE; Mesters RM
Leuk Res; 2008 Jun; 32(6):954-61. PubMed ID: 18006056
[TBL] [Abstract][Full Text] [Related]
18. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression.
Sadick H; Riedel F; Naim R; Goessler U; Hörmann K; Hafner M; Lux A
Haematologica; 2005 Jun; 90(6):818-28. PubMed ID: 15951295
[TBL] [Abstract][Full Text] [Related]
19. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in human malignant melanoma and their relation to angiogenesis.
Tu YT; Tao J; Liu YQ; Li Y; Huang CZ; Zhang XB; Lin Y
Clin Exp Dermatol; 2006 May; 31(3):413-8. PubMed ID: 16681591
[TBL] [Abstract][Full Text] [Related]
20. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
Shang ZJ; Li JR
J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
